Umuthi omusha ukhawulela ukusabalala komdlavuza webele

Ucwaningo lwakamuva lwezokwelapha luveze ukuthi umuthi omusha womdlavuza webele ungabambezela lesi sifo izinyanga ezintathu futhi ube nemiphumela engemihle embalwa.

Umuthi ohlolwayo, owaziwa ngokuthi "i-TDM1," usebenza ngokumelene nohlobo lomdlavuza webele oluyingozi kakhulu, kanti isidakamizwa esithi "Herceptin" sixutshwa ne-chemotherapy ngethamo elilodwa, futhi izivivinyo zibonise ukuthi umuthi omusha uvimbela umdlavuza webele osezingeni eliphezulu ukuthi ungabi mubi kakhulu. izinyanga ezintathu uma kuqhathaniswa nokwelashwa okujwayelekile.Ngasikhathi sinye, kunciphisa imiphumela eqeda amandla yokwelashwa ngamakhemikhali.

Lesi sidakamizwa sithathwa njengesokuqala sohlobo lwaso lomdlavuza webele futhi sisebenza ngokunamathisela engxenyeni yengqamuzana ye-carcinogenic futhi sivimbele ukuthi singakhuli futhi sisakazeke, sibe sisendleleni eya engqamuzaneni ngesikhathi esifanayo futhi sikhipha i-chemotherapy enobuthi ngaphakathi. .

Ocwaningweni lwabantu abacishe babe yi-2 abanomdlavuza osuthuthukile we-HER1-positive, iziguli ezine kweziyishumi zasabela ku-TDMXNUMX, uma kuqhathaniswa nabangaphansi kwengxenye eyodwa kwezintathu yalabo ababethola ukwelashwa okujwayelekile.

USolwazi uPaul Ellis waseGuy’s Hospital eLondon uthe: “Lokhu okutholakele kuyaphawuleka ngoba ngokokuqala ngqa kumdlavuza webele, sikwazile ukuthuthukisa kakhulu ukusebenza kahle ngesikhathi esifanayo sehlisa imiphumela eminingi engemihle ehlobene nokwelashwa ngamakhemikhali.”

Ngakolunye uhlangothi, uMqondisi weBritish Breast Cancer Research Society, uDkt. Lisa Wild Lolu cwaningo luyintuthuko enhle ezigulini ezinomdlavuza webele we-HER2 othuthukisiwe okwamanje ezinezinketho zokwelashwa ezilinganiselwe.

Ngenhlanhla, umdlavuza webele ungomunye wemidlavuza engelapheka unomphela uma usheshe watholakala, futhi yilokhu esikubiza kubo bonke abesifazane abaneminyaka engaphezu kuka-25 ubudala.